Digestion, Digestive Health
Conditions
Keywords
Gastrointestinal Symptoms, Hormonal Bloating, Capsule Supplement
Brief summary
This virtual single-group study aims to evaluate the efficacy of Bye Bye Bloat Capsules in relieving hormonal and food-related bloating and promoting healthy digestion. The study will last 4 weeks, involving 40 female participants aged 18+ who will take two capsules after meals and during times of bloating. Measurements and questionnaires will be completed at Baseline, first use, Week 2, and Week 4.
Interventions
DIETARY_SUPPLEMENTBye Bye Bloat Capsules
Bye Bye Bloat Capsules contain the following ingredients: Organic Fenugreek Seed Powder, Organic Dandelion Root Powder, Organic Fennel Seed Powder, Organic Ginger Root Powder, Organic Parsley Leaf Powder, Amylase Complex, Protease Complex, Pepsin Complex, Lipase Complex, Bromelain Complex, Papain Complex. Other ingredients include Hypromellose Capsule, Maltodextrin, Microcrystalline Cellulose, and Magnesium Stearate. Participants will take 2 capsules immediately after eating at least 3 times a week and during times of hormonal bloating for 4 weeks.
Sponsors
Citruslabs
Love Wellness
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Women aged 18+ * Self-reported concerns with bloating after eating * Issues with hormonal bloating * Generally healthy without uncontrolled chronic diseases * Willing to avoid using digestive health remedies and other oral supplements during the study
Exclusion criteria
* Pre-existing chronic conditions preventing adherence to the protocol * Undergoing procedures related to digestive health * Started new medications or supplements targeting digestive health in the past 3 months * Severe allergic reactions requiring an Epi-Pen * Pregnant, breastfeeding, or attempting to conceive * Unwilling to follow the study protocol * Recent surgeries or planned surgeries during the study * Diagnosed gastrointestinal disorders * Recent changes in hormonal birth control use
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in Bloating | Baseline, first use, Week 2, and Week 4 | Evaluation of parameters associated with hormonal and food-related bloating through self-reported questionnaires taken at Baseline, first use, Week 2, and Week 4. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in Digestion and Mental Well-being | Baseline, first use, Week 2, and Week 4 | Assessment of changes in participant perception of digestion, gas, mental health, and well-being associated with bloating through self-reported questionnaires taken at Baseline, first use, Week 2, and Week 4. |
Countries
United States
Outcome results
None listed